Morepen Laboratories share news, announcements and annual reports
NSE: MOREPENLABBSE: 500288Pharmaceuticals & BiotechnologySmall Cap
Morepen Laboratories Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 1993 on BSE, Nov 1999 on NSE
Last close ₹125.58down ₹6.60 (4.99%)BSE ₹125.90
Share price at the NSE close on 28 Oct 2026. Previous close ₹132.18.
28 Oct: open ₹128.00, high ₹130.55, low ₹125.58
52-week range of traded prices to 28 Oct 2026
₹33.05Low, 30 Mar 2026₹150.70High, 7 Oct 2026
- Under NSE's long-term additional surveillance, stage IV, on the list for 28 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6,881 Cr1,108th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 36.50
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.98
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.16%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 14.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.22
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 51,15,994
Morepen Laboratories has 606 announcements on record, routine notices left out; 6 in the 30 days to 28 Oct 2026, the latest on 27 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Morepen Laboratories quarterly results
Oct27Tue
The board met on 27 Oct 2026 to consider financial results
Notice filed 22 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Morepen Laboratories annual reports, presentations and earnings calls
The company's own documents, latest first.Morepen Laboratories financials, year by year
Annual reports17
- Annual report, year to Mar 20262 Sep 2026
- Annual report, year to Mar 202512 Aug 2025
- Annual report, year to Mar 20244 Sep 2024
- Annual report, year to Mar 20234 Sep 2023, a zip file
- Annual report, year to Mar 20222 Sep 2022, a zip file
12 earlier reports
- Annual report, year to Mar 20214 Sep 2021, a zip file
- Annual report, year to Mar 20205 Sep 2020, a zip file
- Annual report, year to Mar 201920 Aug 2019, a zip file
- Annual report, year to Mar 201825 Sep 2018, a zip file
- Annual report, year to Mar 201729 Sep 2017, a zip file
- Annual report, year to Mar 201626 Sep 2016, a zip file
- Annual report, year to Mar 201521 Aug 2015, a zip file
- Annual report, year to Mar 201420 Aug 2014, a zip file
- Annual report, year to Mar 201320 Aug 2013, a zip file
- Annual report, year to Mar 201218 Sep 2012, a zip file
- Annual report, year to Mar 201013 Apr 2011, a zip file
- Annual report, year to Mar 200918 Aug 2010, a zip file
Investor presentations38
- Investor Presentation27 Oct 2026
- Investor Presentation4 Aug 2026
- Investor Presentation27 May 2026
- Investor Presentation10 Feb 2026
- Investor Presentation14 Nov 2025
33 earlier presentations
- Investor Presentation6 Aug 2025
- Investor Presentation12 May 2025
- Investor Presentation6 Feb 2025
- Investor Presentation11 Nov 2024
- Investor Presentation12 Aug 2024
- Investor Presentation22 May 2024
- Investor Presentation21 May 2024
- Corporate Presentation15 Apr 2024
- Investor Presentation31 Jan 2024
- Investor Presentation2 Nov 2023
- Investor Presentation7 Aug 2023
- Investor Presentation16 May 2023
- Investor Presentation13 Feb 2023
- Investor Presentation10 Nov 2022
- Investor Presentation29 Jul 2022
- Investor Presentation5 May 2022
- Investor Presentation8 Feb 2022
- Investor Presentation11 Nov 2021
- Investor Presentation27 Jul 2021
- Investor Presentation4 May 2021
- Investor Presentation12 Feb 2021
- Investor Presentation9 Nov 2020
- Investor Presentation31 Aug 2020
- Investor Presentation22 Jun 2020
- Investor Presentation17 Feb 2020
- Investor Presentation13 Nov 2019
- Investor Presentation13 Aug 2019
- Investor Presentation6 May 2019
- Investor Presentation4 Feb 2019
- Investor Presentation Q2 September, 2018, based on the financial performance of the Company for the Quarter and Half-year ended 30th September, 2018.1 Nov 2018
- Investor Presentation13 Aug 2018, a zip file
- Investor Presentation16 May 2018, a zip file
- Investor Presentation22 Jan 2018, a zip file
Earnings calls20
- Transcript17 May 2025
- Link of Recording13 May 2025
- Transcript12 Feb 2025
- Link of Audio Recording6 Feb 2025
- Transcript19 Nov 2024
15 earlier call documents
- Link of Recording12 Nov 2024
- Transcript17 Aug 2024
- Link of Recording14 Aug 2024
- Transcript of earnings conference call held on Wednesday, 22nd May 2024.28 May 2024
- Link of Audio Recording22 May 2024
- Transcript of Earnings Conference Call held on 1-Feb-2024.3 Feb 2024
- Link of Audio Recording1 Feb 2024
- Transcript8 Nov 2023
- Link of Recording3 Nov 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call11 May 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call6 May 2022
- Transcript of Analyst/ Investor Conference Call organised on Wednesday,9th February 2022 at 04:00 P.M. (IST), subsequent to the declaration of unaudited standalone andconsolidated financial results for the quarter and nine months ended 31st December, 2021.12 Feb 2022
- Transcript18 Nov 2021
- Transcript of Investor and Analysts Con. Call on results for Q1 FY20-21 held on 1st September, 20207 Sep 2020
- Transcript of Conference Call held on 29th June, 20203 Jul 2020
Morepen Laboratories share news and announcements
Newest first. Page 1 of 13.
Oct 2026
27 Oct · Management
27 Oct · Results
22 Oct · Board meeting
14 Oct
Sep 2026
22 Sep · General Updates
7 Sep · General Updates
2 Sep · Meeting
Aug 2026
6 Aug · General Updates
4 Aug · Business
4 Aug · Results
Jul 2026
23 Jul · General Updates
6 Jul · Management
Jun 2026
30 Jun · Management
9 Jun · Legal
The exchange asked on 9 Jun 2026
May 2026
26 May · Amendment(s)
20 May
15 May · Board meeting
Board Meeting to be held on 22-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 .
Apr 2026
23 Apr · Business
Mar 2026
11 Mar · Updates
Feb 2026
23 Feb · Business
11 Feb · General Updates
Jan 2026
Dec 2025
4 Dec · General Updates
Nov 2025
14 Nov · Results
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 27 Oct 2026Resultsup 4.90%+4.3 pts vs Nifty 500market median −0.7% · volume 0.6× usual · The announcement
- 4 Aug 2026Resultsup 20.00%+20.5 pts vs Nifty 500market median −0.7% · five sessions +37.3% (+37.6 pts vs Nifty 500) · volume 8.7× usual · delivery −4.1 pts against usual · The announcement
- 7 Jul 2026Board or managers changedup 0.67%+1.0 pts vs Nifty 500market median 0.0% · five sessions +2.5% (+2.9 pts vs Nifty 500) · volume 0.6× usual · delivery −3.6 pts against usual · The announcement
- 1 Jul 2026Board or managers changedup 6.02%+5.5 pts vs Nifty 500market median 0.0% · five sessions +3.5% (+1.9 pts vs Nifty 500) · volume 2.5× usual · delivery −9.3 pts against usual · The announcement
- 10 Feb 2026Resultsup 1.04%+0.7 pts vs Nifty 500market median −0.7% · five sessions −3.8% (−3.0 pts vs Nifty 500) · volume 3.1× usual · delivery −12.3 pts against usual · The announcement
- 14 Nov 2025Resultsdown 0.69%−0.8 pts vs Nifty 500market median −0.7% · five sessions −3.8% (−4.4 pts vs Nifty 500) · volume 2.2× usual · delivery −12.9 pts against usual · The announcement
- 25 Aug 2025Credit ratingdown 1.65%−1.9 pts vs Nifty 500market median 0.0% · five sessions −2.2% (−1.0 pts vs Nifty 500) · volume 0.5× usual · delivery +9.3 pts against usual · The announcement
- 7 Aug 2025Resultsdown 6.71%−6.8 pts vs Nifty 500market median −0.7% · five sessions −11.4% (−11.5 pts vs Nifty 500) · volume 5.1× usual · delivery +6.5 pts against usual · The announcement
- 5 Jun 2025Board or managers changedup 1.03%+0.5 pts vs Nifty 500market median 0.0% · five sessions +5.6% (+3.3 pts vs Nifty 500) · volume 0.5× usual · delivery +0.7 pts against usual · The announcement
- 13 May 2025Dividenddown 0.31%+0.4 pts vs Nifty 500market median 0.0% · five sessions +5.5% (+3.9 pts vs Nifty 500) · volume 0.9× usual · delivery +0.2 pts against usual · The announcement
20 earlier announcements
- 13 May 2025Resultsdown 0.31%+0.4 pts vs Nifty 500market median −0.7% · five sessions +5.5% (+3.9 pts vs Nifty 500) · volume 0.9× usual · delivery +0.2 pts against usual · The announcement
- 6 May 2025Board or managers changeddown 5.63%−4.6 pts vs Nifty 500market median 0.0% · five sessions −1.1% (−2.6 pts vs Nifty 500) · volume 0.6× usual · delivery +6.4 pts against usual · The announcement
- 29 Apr 2025Board or managers changedup 0.93%+0.9 pts vs Nifty 500market median 0.0% · five sessions −7.2% (−6.5 pts vs Nifty 500) · volume 1.1× usual · delivery −13.3 pts against usual · The announcement
- 4 Dec 2024Board or managers changedup 0.40%+0.1 pts vs Nifty 500market median 0.0% · five sessions −0.2% (−1.5 pts vs Nifty 500) · volume 1.2× usual · delivery −1.9 pts against usual · The announcement
- 12 Aug 2024Resultsup 1.58%+1.6 pts vs Nifty 500market median −0.7% · five sessions +20.5% (+19.5 pts vs Nifty 500) · volume 3.7× usual · delivery −6.2 pts against usual · The announcement
- 30 Apr 2024Board or managers changeddown 0.99%−1.0 pts vs Nifty 500market median 0.0% · five sessions −7.8% (−6.1 pts vs Nifty 500) · volume 0.5× usual · delivery +10.0 pts against usual · The announcement
- 1 Apr 2024Board or managers changedup 8.09%+6.9 pts vs Nifty 500market median 0.0% · five sessions +14.1% (+11.9 pts vs Nifty 500) · volume 1.4× usual · delivery −1.6 pts against usual · The announcement
- 2 Mar 2024Board or managers changedup 3.25%+2.9 pts vs Nifty 500market median 0.0% · five sessions −5.3% (−5.7 pts vs Nifty 500) · volume 0.1× usual · delivery +28.2 pts against usual · The announcement
- 31 Jan 2024Resultsup 13.18%+12.0 pts vs Nifty 500market median −0.7% · five sessions +17.0% (+14.7 pts vs Nifty 500) · volume 6.8× usual · delivery −8.6 pts against usual · The announcement
- 1 Dec 2023Board or managers changeddown 1.53%−2.2 pts vs Nifty 500market median 0.0% · five sessions −5.0% (−9.0 pts vs Nifty 500) · volume 0.8× usual · delivery −2.1 pts against usual · The announcement
- 20 Sep 2023Board or managers changeddown 1.34%−0.4 pts vs Nifty 500market median 0.0% · five sessions −2.0% (−0.1 pts vs Nifty 500) · volume 0.4× usual · delivery −9.3 pts against usual · The announcement
- 7 Aug 2023Board or managers changedup 8.36%+8.0 pts vs Nifty 500market median 0.0% · five sessions +13.8% (+14.0 pts vs Nifty 500) · volume 10.0× usual · delivery −11.8 pts against usual · The announcement
- 1 Aug 2023Board or managers changeddown 0.97%−0.9 pts vs Nifty 500market median 0.0% · five sessions +6.4% (+7.0 pts vs Nifty 500) · volume 1.0× usual · delivery +3.0 pts against usual · The announcement
- 10 Nov 2022Results0.00%+0.8 pts vs Nifty 500market median −0.7% · five sessions +4.7% (+4.1 pts vs Nifty 500) · volume 0.8× usual · delivery −4.8 pts against usual · The announcement
- 23 Jun 2022Board or managers changeddown 0.84%−1.8 pts vs Nifty 500market median 0.0% · five sessions +2.8% (0.0 pts vs Nifty 500) · volume 0.6× usual · delivery −3.8 pts against usual · The announcement
- 4 Apr 2022Board or managers changedup 3.17%+1.2 pts vs Nifty 500market median 0.0% · five sessions +8.2% (+6.5 pts vs Nifty 500) · volume 3.3× usual · delivery −16.4 pts against usual · The announcement
- 8 Feb 2022Resultsdown 6.48%−6.4 pts vs Nifty 500market median −0.7% · five sessions −17.3% (−14.1 pts vs Nifty 500) · volume 2.7× usual · delivery −2.7 pts against usual · The announcement
- 27 Jul 2021Resultsup 2.55%+3.0 pts vs Nifty 500market median −0.7% · five sessions −3.1% (−3.9 pts vs Nifty 500) · volume 1.8× usual · delivery −17.1 pts against usual · The announcement
- 4 May 2021Resultsdown 4.95%−4.2 pts vs Nifty 500market median −0.7% · five sessions −13.9% (−16.1 pts vs Nifty 500) · volume 0.9× usual · delivery +18.7 pts against usual · The announcement
- 9 Nov 2020Resultsup 7.64%+6.2 pts vs Nifty 500market median −0.7% · five sessions +2.0% (−1.5 pts vs Nifty 500) · volume 5.9× usual · delivery −10.2 pts against usual · The announcement
Morepen Laboratories results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.